Market Insights on Eli Lilly and Bristol Myers: Future Prospects and Innovations

This chapter explores the market performance and future prospects of Eli Lilly and Bristol Myers, highlighting potential FDA decisions and advancements in drug treatments. The discussion emphasizes optimism regarding innovative therapies for schizophrenia and weight management amid competition from other pharmaceutical companies.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app